KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Kumquat Biosciences Inc.
Kumquat Biosciences Inc.
Turning Point Therapeutics, Inc.
Eisai Inc.
Theseus Pharmaceuticals
Hoffmann-La Roche
Aesculap AG
Novartis
Novartis